Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants

S. B. Hall, A. R. Venkitaraman, J. A. Whitsett, B. A. Holm, R. H. Notter

Research output: Contribution to journalArticle

150 Scopus citations

Abstract

The biophysical properties and physiologic effects of a series of clinical exogenous pulmonary surfactants was compared to determine the importance of the hydrophobic apoproteins (SP-B and C) as constituents of these preparations. The three exogenous surfactants studied, calf lung surfactant extract (CLSE), Survanta® (Surfactant-TA), and Exosurf®, all contain dipalmitoyl phosphatidylcholine (DPPC) as their major constituent. CLSE and Survanta also contain 1 to 2% of SP-B,C but Exosurf has the additives hexadecanol and tyloxapol instead to enhance the activity of DPPC. In adsorption experiments, CLSE reached a final surface tension of 22 mN/m, and Survanta and Exosurf reached 28 and 38 mN/m, respectively. Addition of 1% by weight of an apoprotein isolate containing both SP-B and C to Exosurf slightly improved its adsorption. In oscillating bubble studies, CLSE and Survanta decreased surface tension to low values of < 1 and 2 mN/m, respectively, but Exosurf achieved a minimum value of only 29 mN/m. Addition of SP-B,C to Exosurf improved this minimum to 1 mN/m and approached the behavior of mixtures of synthetic DPPC with SP-B,C. In both adsorption and pulsating bubble experiments, the minimum surface tensions found for Exosurf were almost identical to those generated by tyloxapol alone. In studies of physiologic activity, 20 mg of CLSE or Survanta restored the pressure-volume mechanics of lavaged, surfactant-deficient excised rat lungs to 95 and 50%, respectively, of normal prelavage levels. Instillation of Exosurf (37.5 mg) produced a minimal improvement of only 10% compared to 70% for mixtures containing 1% SP-B,C with either Exosurf or DPPC. These results show that SP- B and C are significantly more effective than hexadecanol and tyloxapol in enhancing the surface and physiologic activity of DPPC in the exogenous surfactants studied. The disparity between our measurements of poor surface activity and previous reports of clinical benefits from Exosurf in premature infants with the respiratory distress syndrome suggests that the mechanism(s) of its effect may involve factors unrelated to its intrinsic surface properties, such as by combination with endogenous apoproteins or incorporation into recycling pathways.

Original languageEnglish (US)
Pages (from-to)24-30
Number of pages7
JournalAmerican Review of Respiratory Disease
Volume145
Issue number1
DOIs
StatePublished - Jan 1 1992

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants'. Together they form a unique fingerprint.

  • Cite this